These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 421187)

  • 1. Blood group isoantigen deletion in carcinoma in situ of the urinary bladder.
    Weinstein RS; Alroy J; Farrow GM; Miller AW; Davidsohn I
    Cancer; 1979 Feb; 43(2):661-8. PubMed ID: 421187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of blood-group-related antigens in carcinoma in situ of the urinary bladder.
    Coon JS; McCall A; Miller AW; Farrow GM; Weinstein RS
    Cancer; 1985 Aug; 56(4):797-804. PubMed ID: 4016671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of ABO(H) isoantigen expression in bladder tumors.
    Srinivas V; Orihuela E; Lloyd KO; Old LJ; Whitmore WF
    J Urol; 1985 Jan; 133(1):25-8. PubMed ID: 3964875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of ABH antigenicity of random mucosal biopsies and transitional cell carcinoma of the urinary bladder.
    Jakse G; Hofstädter F
    Eur Urol; 1983; 9(2):97-101. PubMed ID: 6852091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A, B and O(H) isoantigens in tumor of the urinary bladder. Preliminary results, relating the specific red cell adherence test to pathological grade and stage.
    Karlsen S; Jordfald G; Svaar H
    Urol Int; 1984; 39(3):150-3. PubMed ID: 6740805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The distribution of ABO(H) isoantigens in urinary bladder tumours.
    Baranyay F; Knels R; Somogyi L
    Acta Med Hung; 1992-1993; 49(1-2):129-36. PubMed ID: 1296182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ABH isoantigen of superficial urothelial tumor and carcinoma in situ of the bladder by the avidin-biotin peroxidase complex(ABC) method].
    Sasaki K
    Nihon Hinyokika Gakkai Zasshi; 1983 Aug; 74(8):1326-38. PubMed ID: 6374223
    [No Abstract]   [Full Text] [Related]  

  • 8. [Significance of isoantigen in the management of the urinary bladder tumor--a basic study of ABO isoantigen in step sections of the entire bladder].
    Ogawa T; Sugimoto M; Hamami G; Kamidono S
    Hinyokika Kiyo; 1989 Jan; 35(1):13-25. PubMed ID: 2729014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoantigens A, B and H in urinary bladder carcinomas following radiotherapy.
    Alroy J; Teramura K; Miller AW; Pauli BU; Gottesman JE; Flanagan M; Davisohn I; Weinstein RS
    Cancer; 1978 May; 41(5):1739-45. PubMed ID: 647623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of action of intravesical treatment. Effect on the ABH surface antigens of urothelial cells.
    Jakse G; Hofstädter F
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S74-8. PubMed ID: 6640839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of A, B and H(O) antigens in normal and neoplastic epithelium of the urinary bladder by the specific red cell adherence test (SRCA).
    Kato T
    Tohoku J Exp Med; 1977 Mar; 121(3):239-46. PubMed ID: 857340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of the A, B and H isoantigens in single transitional carcinoma cells.
    Borgström E; Wahren B
    J Urol; 1985 Jul; 134(1):199-202. PubMed ID: 3892047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood group antigens and bladder carcinoma: a perspective.
    Stein BS; Kendall AR
    Urology; 1982 Sep; 20(3):229-33. PubMed ID: 7123712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on blood group isoantigens in uroepithelium. I. Determination of isoantigens in non-malignant epithelium of tumor-bearing bladder].
    Abe R
    Nihon Hinyokika Gakkai Zasshi; 1985 Jul; 76(7):1049-58. PubMed ID: 4079195
    [No Abstract]   [Full Text] [Related]  

  • 15. ABH antigenicity of in situ carcinoma of the urinary bladder during intracavity treatment with doxorubicin hydrochloride.
    Jakse G; Hofstädter F
    Urol Res; 1981; 9(3):153-6. PubMed ID: 7257030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The study of ABH isoantigen and T (Thomsen-Friedenreich) antigen of superficial urothelial tumor].
    Sasaki K
    Hokkaido Igaku Zasshi; 1984 Nov; 59(6):679-89. PubMed ID: 6530208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in the expression of the O(H) antigen in human transitional epithelium.
    Coon JS; Weinstein RS
    J Urol; 1981 Mar; 125(3):301-6. PubMed ID: 7206077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence methods for measuring the A, B, and H isoantigens on cytological material from bladder carcinoma.
    Borgström E; Wahren B; Gustafson H
    Urol Res; 1985; 13(2):43-5. PubMed ID: 3892840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoma in situ of the bladder.
    Hudson MA; Herr HW
    J Urol; 1995 Mar; 153(3 Pt 1):564-72. PubMed ID: 7861485
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical significance of A, B, H isoantigen deletion of urothelial cells in bladder carcinoma.
    Borgström E; Wahren B
    Cancer; 1986 Dec; 58(11):2428-34. PubMed ID: 3768837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.